Product Information
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $1.1353 per EA under NDC 62559066290. Its NADAC has been published 385 times since Feb 13, 2019.
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB
Candesartan Cilexetil and HydrochlorothiazideStrength
32; 25 mg/1; mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559066290
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021093On Market Since
9/26/2018
Pharmacological Classes
Price Statistics
The NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB has been published 385 times since Feb 13, 2019, and over the history we have for it it has declined 72.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1353 per EA |
|---|---|
| All-time high | $4.1187 (Mar 13, 2019) |
| All-time low | $0.9491 (Oct 22, 2025) |
| 52-week high | $1.2433 |
| 52-week low | $0.9491 |
| Median price | $1.6288 |
| Average price | $1.7256 |
| Largest weekly change | +149.4% (Apr 21, 2021) |
| Weeks tracked | 385 |
| Tracking since | Feb 13, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB, manufactured by ANI Pharmaceuticals, Inc., is $1.1353 per EA (NDC 62559066290), effective Jun 24, 2026.
How has the price of CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB changed over time?
Over the history we have for it, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB has declined 72.4%. It has been tracked across 385 weekly CMS publications since Feb 13, 2019.
What are the highest and lowest recorded NADAC prices for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?
Since Feb 13, 2019, the NADAC for CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB has ranged from a low of $0.9491 (Oct 22, 2025) to a high of $4.1187 (Mar 13, 2019), with a median of $1.6288 per EA.
Are there cheaper alternatives to CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB, but none are currently priced below it.
Who manufactures CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB?
CANDESARTAN-HYDROCHLOROTHIAZIDE 32-25 MG TAB (NDC 62559066290) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification